Bonesupport Holding Unternehmensprofil

Unternehmensprofil

Bonesupport Holding hat 171 Mitarbeiter und den Hauptsitz in Lund, Schweden.

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Beschreibung auf Englisch verfügbar.

Unternehmensdaten

Branche

Gesundheit

Industrie

Medical Instruments & Supplies

Land

Schweden

Hauptsitz

Scheelevägen 19, 223 70, Lund

Mitarbeitende

171

Notierung

BONEX · Nasdaq Stockholm

Währung

SEK

ISIN

SE0009858152

Website

bonesupport.com